Summary

Executive Summary

The Global Transcatheter Tricuspid Valve Intervention (TTVI) market is projected to display noteworthy growth and estimated to reach value of USD 10.17 billion by the year 2030 with Europe region leading the regional market share. Demand for transcatheter valvular therapeutics for tricuspid valve diseases in line with rising aged population globally that are more prone to such diseases is likely to boost the market growth. Moreover, tricuspid valve intervention (repair and replacement) device developments and their upcoming medical approvals across countries is also creating positive outlook for the market growth.

European region is estimated to be the fastest growing regional market for the TTVI in the forecast period of 2021-25, whereas Asia-Pacific will take the lead in the second half from 2026-30. The growth of the European market can be attributed to early approvals of some tricuspid valve repair devices, rising burden of tricuspid valve disorders, ageing population and high per-capita healthcare spending in regional countries. Whereas, APAC region growth will witness lucrative growth owing to factors like huge unmet needs of patients suffering from tricuspid valve disorders, rapidly expanding healthcare infrastructure, surge in medical tourism and rising healthcare spending by both public and private sectors in the regional countries. Meanwhile, North America will hold the second biggest share in TTVI market and will grow at a robust pace as well.

The emergence of COVID-19 has brought the world to a standstill. This health crisis has brought an unprecedented impact on businesses across industries, including the cardiovascular (heart) care and other related industries. The COVID-19 epidemic has disrupted the clinical & confirmatory trials, pipeline milestones, or regulatory clearances and approvals of tricuspid valve repair & replacement devices in different nations because of lockdowns, travel boycotts, and implementation of “stay-at-home” orders. With the suspension or delay of screening, medical association’s approvals and clinical trial activities, COVID-19 has fundamentally reshaped clinical & surgical practice at every level.

Rising prevalence of tricuspid valve diseases, increasing preference for transcatheter tricuspid valve intervention devices for treatment, and technological advancements leading to enhanced applications of Transcatheter Tricuspid Valve Intervention. Furthermore, the growing preference for minimally-invasive surgeries over traditional/open heart surgeries will drive the utilization of TTVI procedures, such as valve repair and replacement interventions. These factors, in turn, are projected to fuel the demand for Transcatheter Tricuspid Valve Intervention over the coming years.

Scope of the Report

• The report analyses the Transcatheter Tricuspid Valve Intervention Market by value (USD Millions).

• The report analyses the Transcatheter Tricuspid Valve Intervention Market by Intervention Type (Tricuspid Valve Repair (TVr) and Tricuspid Valve Replacement (TVR)).

• The report analyses the Transcatheter Tricuspid Valve Intervention Market by Disease Type (Tricuspid Regurgitation (TR) and Tricuspid Stenosis (TS))

• The report analyses the Transcatheter Tricuspid Valve Intervention Market by End User (Hospitals, Ambulatory Surgical Centers, Others)

• The Global Transcatheter Tricuspid Valve Intervention Market has been analysed By Region (North America, Europe, Asia Pacific, and LAMEA).

• The Global Transcatheter Tricuspid Valve Intervention Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, India, and Australia).

• The key insights of the report have been presented through the frameworks of SWOT Analysis and Product pipeline. Also, the attractiveness of the market has been presented by region, by Intervention Type, by Disease Type and by End User.

• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product developments. The companies analysed in the report include Edwards Lifesciences, Abbott, Medtronic PLC, LivaNova PLC, CryoLife, Venus MedTech, NaviGate Cardiac Structures, Jenscare Biotech., Huihe Medical, and 4Tech Cardio Ltd.

• The report presents the analysis of Transcatheter Tricuspid Valve Intervention Market for the forecast period of 2021-2030.

Key Target Audience

• Transcatheter Tricuspid Valve Intervention Products Manufacturers

• Pharmaceutical Industry

• Biotechnology Companies

• Government and Research Organisations

• Consulting and Advisory Firms

• Investment Banks and Equity Firms

ページTOPに戻る

Table of Contents

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. Transcatheter Tricuspid Valve Intervention (TTVI) Market: Intervention Overview

4. Global Transcatheter Tricuspid Valve Intervention Market: An Analysis

4.1 Market Size, By Value, Year 2021-2030

4.2 Global Transcatheter Tricuspid Valve Intervention Market: Growth & Forecast

4.3 Impact of COVID-19 on Transcatheter Tricuspid Valve Intervention Market

5. Global Transcatheter Tricuspid Valve Intervention Market Segmentation, By Intervention Type (Value)

5.1 Competitive Scenario of Global Transcatheter Tricuspid Valve Intervention Market: By Intervention Type

5.2 Global Transcatheter Tricuspid Valve Intervention Market: Segment Analysis

5.3 By Tricuspid Valve Repair Intervention Type– Market Size and Forecast (2021-2030)

5.4 By Tricuspid Valve Replacement Intervention Type– Market Size and Forecast (2021-2030)

6. Global Transcatheter Tricuspid Valve Intervention Market Segmentation, By Disease Type (Value)

6.1 Competitive Scenario of Global Transcatheter Tricuspid Valve Intervention Market: By Disease Type (2025 & 2030)

6.2 Global Transcatheter Tricuspid Valve Intervention Market: Segment Analysis

6.3 By Tricuspid Regurgitation– Market Size and Forecast (2021-2030)

6.4 By Tricuspid Stenosis– Market Size and Forecast (2021-2030)

7. Global Transcatheter Tricuspid Valve Intervention Market Segmentation, By End User (Value)

7.1 Competitive Scenario of Global Transcatheter Tricuspid Valve Intervention Market: By End User (2025 & 2030)

7.2 Global Transcatheter Tricuspid Valve Intervention Market: Segment Analysis

7.3 By Hospitals– Market Size and Forecast (2021-2030)

7.4 By Ambulatory Surgical Centers– Market Size and Forecast (2021-2030)

7.5 By Others– Market Size and Forecast (2021-2030)

8. Global Transcatheter Tricuspid Valve Intervention Market: Regional Analysis

8.1 Competitive Scenario of Global Transcatheter Tricuspid Valve Intervention Market: By Region (2025 & 2030)

9. North America Transcatheter Tricuspid Valve Intervention Market: An Analysis (2021-2030)

9.1 North America Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030), By Value

9.2 North America Transcatheter Tricuspid Valve Intervention Market – Prominent Companies

9.3 Market Segmentation By Intervention Type (Tricuspid Valve Repair and Tricuspid Valve Replacement)

9.4 Market Segmentation By Disease Type (Tricuspid Regurgitation and Tricuspid Stenosis)

9.5 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Others)

9.6 North America Transcatheter Tricuspid Valve Intervention Market: Country Analysis

9.7 Market Opportunity Chart of North America Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2030)

9.8 Competitive Scenario of North America- By Country

9.9 United States Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030), By Value

9.10 United States Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

9.11 Canada Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030), By Value

9.12 Canada Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

10. Europe Transcatheter Tricuspid Valve Intervention Market: An Analysis (2021-2030)

10.1 Europe Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030), By Value

10.2 Europe Transcatheter Tricuspid Valve Intervention Market: Prominent Companies

10.3 Market Segmentation By Intervention Type (Tricuspid Valve Repair and Tricuspid Valve Replacement)

10.4 Market Segmentation By Disease Type (Tricuspid Regurgitation and Tricuspid Stenosis)

10.5 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Others)

10.6 Europe Transcatheter Tricuspid Valve Intervention Market: Country Analysis

10.7 Market Opportunity Chart of Europe Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2030)

10.8 Competitive Scenario of Europe Transcatheter Tricuspid Valve Intervention Market– By Country (2025 & 2030)

10.9 Germany Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

10.10 Germany Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

10.11 United Kingdom Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

10.12 United Kingdom Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

10.13 Italy Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

10.14 Italy Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

10.15 France Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

10.16 France Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

11. Asia Pacific Transcatheter Tricuspid Valve Intervention Market: An Analysis (2021-2030)

11.1 Asia Pacific Transcatheter Tricuspid Valve Intervention Market by value: Size and Forecast (2021-2030)

11.2 Asia Pacific Transcatheter Tricuspid Valve Intervention Market: Prominent Companies

11.3 Market Segmentation By Intervention Type (Tricuspid Valve Repair and Tricuspid Valve Replacement)

11.4 Market Segmentation By Disease Type (Tricuspid Regurgitation and Tricuspid Stenosis)

11.5 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Others)

11.6 Asia Pacific Transcatheter Tricuspid Valve Intervention Market: Country Analysis

11.7 Market Opportunity Chart of Asia Pacific Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2030)

11.8 Competitive Scenario of Asia Pacific Transcatheter Tricuspid Valve Intervention Market– By Country (2025 & 2030)

11.9 China Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

11.10 China Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

11.11 Japan Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

11.12 Japan Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

11.13 India Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

11.14 India Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

11.15 Australia Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)

11.16 Australia Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)

12. Global Transcatheter Tricuspid Valve Intervention Market Dynamics

12.1 Global Transcatheter Tricuspid Valve Intervention Market Drivers

12.2 Global Transcatheter Tricuspid Valve Intervention Market Restraints

12.3 Global Transcatheter Tricuspid Valve Intervention Market Trends

13. Market Attractiveness and Strategic Analysis

13.1 Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market – By Intervention Type (Year-2030)

13.2 Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market - By Disease Type (Year-2030)

13.3 Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market - By End User (Year-2030)

13.4 Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market – By Region (Year-2030)

14. Competitive Landscape

14.1 SWOT Analysis– Global Transcatheter Tricuspid Valve Intervention Market

14.2 Global Transcatheter Tricuspid Valve Intervention Market: Product Pipeline

15. Global Transcatheter Tricuspid Valve Intervention Market: Major Technological Innovations, Merger & Acquisitions, Recent Developments

16. Company Profiles (Business Description, Financial Analysis, Business Strategy)

16.1 Edwards Lifesciences

16.2 Abbott Laboratories

16.3 Medtronic PLC

16.4 LivaNova PLC

16.5 CryoLife

16.6 Venus MedTech

16.7 Jenscare Scientific Co.

16.8 4Tech Cardio Ireland Ltd.

16.9 NaviGate Cardiac Structures

16.10 Huihe Medical